Leadoptik

Precision optics for early lung cancer detection.

San Jose, United States · Founded 2022

Employees
11–50
Founded
2022
Business Model
B2B
Last Round
Series ASep 2025
Rounds
2

About

LeadOptik (LEADOPTIK) is a medical device company developing precision optics technology for tissue intelligence and lung cancer detection. Its flagship Last Inch Assessment (LIA) technology provides real-time microstructure imaging to guide bronchoscopic biopsies, helping clinicians confirm needle placement in small lesions. The company received FDA clearance in January 2026 and is headquartered in San Jose, California.

Summary

Leadoptik is a Healthcare company based in San Jose, United States, founded in 2022. Its most recent funding was a Series A round in Sep 2025. Investors include SCP Ventures, SOSV and HAX Growth.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries ASep 2025

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Leadoptik on Indexed.vc
<a href="https://indexed.vc/companies/leadoptik"><img src="https://indexed.vc/api/badge/company/leadoptik" alt="Leadoptik on Indexed.vc" width="260" height="76" /></a>